A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)
-
Published:2023-05
Issue:
Volume:21
Page:100497
-
ISSN:2667-193X
-
Container-title:The Lancet Regional Health - Americas
-
language:en
-
Short-container-title:The Lancet Regional Health - Americas
Author:
Hernández-Bernal Francisco, Ricardo-Cobas Maria C., Martín-Bauta Yenima, Rodríguez-Martínez Ernesto, Urrutia-Pérez Klaudia, Urrutia-Pérez Karen, Quintana-Guerra JoelORCID, Navarro-Rodríguez Zadis, Piñera-Martínez Marjoris, Rodríguez-Reinoso José L., Chávez-Chong Cristina O., Baladrón-Castrillo Idania, Melo-Suárez Grettel, Batista-Izquierdo Alejandro, Pupo-Micó Alexis, Mora-Betancourt Ricardo, Bizet-Almeida Jacqueline, Martínez-Rodríguez Maria C., Lobaina-Lambert Leonardo, Velázquez-Pérez Vivian M., Soler-Díaz Jalimy, Laurencio-Vallina Sandra, Meriño-Hechavarría Tamara, Carmenaty-Campos Norberto, Rodríguez-Montero Enri, Limonta-Fernández Miladys, Alonso-Valdés Marel, Hernández-Rodríguez Reinier, Pimentel-Vázquez Eulogio, Catasús-Álvarez Karem M., Cabrera-Núñez Maria V., Ayala-Ávila Marta, Muzio-González Verena L., Hernández-Bernal Francisco, Ricardo-Cobas Maria C., Martín-Bauta Yenima, Rodríguez-Martínez Ernesto, Urrutia-Pérez Klaudia, Urrutia-Pérez Karen, Quintana-Guerra Joel, Navarro-Rodríguez Zadis, Piñera-Martínez Marjoris, Rodríguez-Reinoso José L., Chávez-Chong Cristina O., Baladrón-Castrillo Idania, Melo-Suárez Grettel, Batista-Izquierdo Alejandro, Pupo-Micó Alexis, Mora-Betancourt Ricardo, Bizet-Almeida Jacqueline, Martínez-Rodríguez Maria C., Lobaina-Lambert Leonardo, Velázquez-Pérez Vivian M., Soler-Díaz Jalimy, Laurencio-Vallina Sandra, Meriño-Hechavarría Tamara, Carmenaty-Campos Norberto, Rodríguez-Montero Enri, Limonta-Fernández Miladys, Alonso-Valdés Marel, Hernández-Rodríguez Reinier, Pimentel-Vázquez Eulogio, Catasús-Álvarez Karem M., Cabrera-Núñez Maria V., Ayala-Ávila Marta, Muzio-González Verena L.
Subject
Public Health, Environmental and Occupational Health,Internal Medicine,Health Policy
Reference29 articles.
1. An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen;Limonta-Fernández;New Biotechnol,2021 2. Demonstrating “Abdala” subunit vaccine thermostability;Izquierdo;BioProcess J,2022 3. Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study);Hernández-Bernal;eClinicalMedicine,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|